Baader Bank Aktiengesellschaft Equillium, Inc. Transaction History
Baader Bank Aktiengesellschaft
- $1.31 Billion
- Q2 2025
A detailed history of Baader Bank Aktiengesellschaft transactions in Equillium, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 23,711 shares of EQ stock, worth $9,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,711Holding current value
$9,010% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
29Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$1.69 Million1.82% of portfolio
-
Decheng Capital LLC Menlo Park, CA4.45MShares$1.69 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$319,9400.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$213,665100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$102,4100.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $13.1M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...